Introduction: Using pharmacy claims data we previously identified exposure misclassification in pharmacy
claims data that underestimated oral bisphosphonate compliance, particularly in long-term care (LTC). In this study
we examined the impact of exposure misclassification in pharmacy claims data on estimates of drug effectiveness
using osteoporosis pharmacotherapy and hip fractures as a case example.
claims data that underestimated oral bisphosphonate compliance, particularly in long-term care (LTC). In this study
we examined the impact of exposure misclassification in pharmacy claims data on estimates of drug effectiveness
using osteoporosis pharmacotherapy and hip fractures as a case example.